CYBERDYNE (7779) AI Stock Analysis

• Market Cap: ¥58.48B
• Dividend Yield: N/A
• Average Volume (3M): 724.97K
• Price to Earnings (P/E): 87.8
• Beta (1Y): 0.84
• Revenue Growth: -4.30%
• EPS Growth: 82.87%
• Country: JP
• Employees: 227
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): 0.57
• Shares Outstanding: 137,445,820
• 10 Day Avg. Volume: 764,380
• 30 Day Avg. Volume: 724,970
• PEG Ratio: 1.05
• Price to Book (P/B): 0.93
• Price to Sales (P/S): 8.43
• P/FCF Ratio: -50.89
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥410.00
• Price Target Upside: 89.81% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 1.03
• Revenue Forecast (FY): ¥4.96B

• Rating: 56 Neutral
• Price Target: ¥285.00 ▲(31.94% Upside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is held back primarily by weak financial performance—ongoing net losses and persistent negative operating/free cash flow—despite a very strong, low-leverage balance sheet. Technicals are a major positive, showing a clear uptrend and strong momentum. Valuation remains unattractive because earnings are negative (negative P/E) and there is no dividend yield data to offset that.

Positive Factors

Balance Sheet Strength

Very low leverage and a stable equity base give the company enduring financial flexibility. Over 2–6 months this supports continued R&D and commercialization spending, allows opportunistic M&A or partnership moves, and reduces refinancing risk while losses narrow.

Negative Factors

Persistent Unprofitability

Consistent net losses mean the business has not yet demonstrated sustainable profitability. Over the next 2–6 months, absence of operating profits keeps pressure on margins and raises dependency on improving revenue mix or large cost reductions to reach self-sustaining earnings.

CYBERDYNE Business Overview & Revenue Model

Company Description

CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL ...

Read more

CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL ...

How the Company Makes Money

CYBERDYNE primarily generates revenue by commercializing its HAL exoskeleton platform and associated services. Key revenue streams include: (1) sales and/or leasing of HAL units to hospitals, rehabilitation centers, and care providers (the specifi...

Read more

CYBERDYNE primarily generates revenue by commercializing its HAL exoskeleton platform and associated services. Key revenue streams include: (1) sales and/or leasing of HAL units to hospitals, rehabilitation centers, and care providers (the specifi...

CYBERDYNE Financial Statement Overview

Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	4.11B	4.38B	4.35B	3.29B	2.15B	1.88B
Gross Profit	2.05B	2.07B	2.03B	1.49B	1.25B	1.11B
EBITDA	-505.00M	-904.00M	-1.06B	-722.00M	-565.00M	-413.00M
Net Income	-3.00M	-577.00M	-1.48B	-298.00M	-498.00M	-59.00M
Balance Sheet
Total Assets	49.00B	48.55B	50.00B	50.19B	49.47B	48.12B
Cash, Cash Equivalents and Short-Term Investments	9.20B	6.82B	5.16B	7.80B	20.83B	6.70B
Total Debt	434.00M	434.00M	632.00M	669.00M	575.00M	421.00M
Total Liabilities	9.21B	8.95B	9.52B	8.20B	6.02B	4.33B
Stockholders Equity	39.80B	39.58B	40.75B	42.10B	43.41B	43.78B
Cash Flow
Free Cash Flow	-222.00M	-726.00M	-1.07B	-594.00M	-2.33B	-1.84B
Operating Cash Flow	-177.00M	-430.00M	-850.00M	-143.00M	-564.00M	-775.00M
Investing Cash Flow	5.56B	2.33B	-2.08B	2.17B	-1.79B	-2.79B
Financing Cash Flow	-226.00M	-216.00M	160.00M	14.00M	1.25B	617.00M

CYBERDYNE Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 216.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7779, the sentiment is Positive. The current price of 216 is below the 20-day moving average (MA) of 291.30, below the 50-day MA of 308.48, and below the 200-day MA of 219.90, indicating a neutral trend. The MACD of -10.76 indicates Positive momentum. The RSI at 45.58 is Neutral, neither overbought nor oversold. The STOCH value of 54.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7779.

CYBERDYNE Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
5187	72 Outperform	¥10.94B	12.19	―	3.52%	4.97%	-10.07%
7963	67 Neutral	¥9.22B	4.38	―	1.89%	9.47%	37.35%
6849	65 Neutral	¥255.67B	36.37	―	1.92%	4.31%	96.31%
7600	63 Neutral	¥14.51B	14.76	―	3.12%	3.59%	-163.08%
7779	56 Neutral	¥58.48B	87.82	-0.46%	―	-4.30%	82.87%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
6523	51 Neutral	¥136.36B	28.05	2.42%	3.73%	0.04%	―

CYBERDYNE Corporate Events